More News

07 Sep 2017 Gritstone Oncology Secures $92.7 Million in Series B Financing
07 Sep 2017 Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments
07 Sep 2017 Iovance Biotherapeutics Enters into a Research Collaboration Focused on Hematologic Malignancies with The Ohio State University Comprehensive Cancer Center
07 Sep 2017 Zealand and Orbit Discovery enter into research collaboration
07 Sep 2017 Evotec and ABIVAX Enter into Strategic Collaboration to Develop Novel Antiviral Agents
06 Sep 2017 Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
06 Sep 2017 Morphotek Announces Collaboration Agreement With The Johns Hopkins University To Research And Develop Novel Monoclonal Antibody-Based Therapies Targeting Missplicing-Associated Surface Antigens
06 Sep 2017 Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
06 Sep 2017 MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor
06 Sep 2017 BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins
06 Sep 2017 Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Haemophilia and Sickle Cell Disease
05 Sep 2017 Retrophin Announces Cooperative Research and Development Agreement with NCATS and NGLY1.org to Identify Potential Small Molecule Therapeutics for NGLY1 Deficiency
05 Sep 2017 $8.7 Million Awarded to Support Phase III Femoral Neck Fracture Trial by EU Horizon 2020 Program
05 Sep 2017 MorphoSys Presents Vision for Growth at its Capital Markets Day
05 Sep 2017 AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round
05 Sep 2017 Axxam Enters Into Research Collaboration with Sanofi in the Field of Neurodegeneration
05 Sep 2017 Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million
04 Sep 2017 Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors
01 Sep 2017 ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB
29 Aug 2017 Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products
29 Aug 2017 Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors
29 Aug 2017 BERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat Neurological Disorders such as Parkinson's Disease
29 Aug 2017 CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
29 Aug 2017 AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease
29 Aug 2017 Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo® (nivolumab) and DS-8201 in HER2-Expressing Breast and Bladder Cancers

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top